Overview

Pharmacokinetic Study of Dexmedetomidine After Intra-nasal Dosing in Children

Status:
Completed
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
This research study is examining the absorption of the sedative dexmedetomidine (DEX) in the blood when given by nasal spray. The study will help us determine the best dosing amount for children undergoing sedation or anesthesia with DEX.
Phase:
Phase 1
Details
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Treatments:
Dexmedetomidine